GUJARAT THEMIS BIOSYN
Back to Cashflow Statement
|
GUJARAT THEMIS BIOSYN Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹5.22 Cr | ₹0.41 Cr | ₹5.79 Cr | ₹-3.51 Cr | ₹3.12 Cr |
What is the latest Net Cash Inflow / Outflow ratio of GUJARAT THEMIS BIOSYN ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹5.22 Cr |
| Mar2024 | ₹0.41 Cr |
| Mar2023 | ₹5.79 Cr |
| Mar2022 | ₹-3.51 Cr |
| Mar2021 | ₹3.12 Cr |
How is Net Cash Inflow / Outflow of GUJARAT THEMIS BIOSYN Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹5.22 Cr | 1,162.08 | |
| Mar2024 | ₹0.41 Cr | -92.85 | |
| Mar2023 | ₹5.79 Cr | Positive | |
| Mar2022 | ₹-3.51 Cr | Negative | |
| Mar2021 | ₹3.12 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of GUJARAT THEMIS BIOSYN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUJARAT THEMIS BIOSYN | ₹4,378.0 Cr | 7.8% | 3.7% | 23.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,803.0 Cr | 2.8% | 1.8% | 13.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,219.0 Cr | -0.2% | -0.1% | 3.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,417.0 Cr | 1.4% | -1.5% | 39.9% | Stock Analytics | |
| CIPLA | ₹116,116.0 Cr | 6% | 1.7% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,874.0 Cr | 4.8% | -0.3% | -0.9% | Stock Analytics | |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUJARAT THEMIS BIOSYN | 7.8% |
3.7% |
23.3% |
| SENSEX | -0.2% |
2.1% |
-5.6% |
You may also like the below Video Courses